All of the stem-cell-based biopharmaceuticals being developed by our company are designed to treat conditions caused by chronic inflammatory diseases. We are developing biopharmaceuticals to treat osteoporosis and atopic dermatitis in dogs, chronic inflammation of the oral cavity as well as gingivitis in cats, and medicines that help heal torn ligaments and treat conditions related to the lower limbs for horses. We talked more about our company, plans and the drugs we are developing in Puls Biznesu.
Publication available only in Polish.